BeautyHealth (NASDAQ:SKIN) Beats Q3 Sales Expectations, Stock Jumps 16.7%

Skincare company BeautyHealth (NASDAQ:SKIN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 10.3% year on year to $70.7 million. The company’s full-year revenue guidance of $296.5 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP loss of $0.09 per share was in line with analysts’ consensus estimates. Is now the time to buy BeautyHealth? Find out in our full research report. BeautyHealth (SKIN) Q3 CY2025 Highlights: Revenue: $70.7 million vs anal ...